If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS: 33818-15-4
Source: Japan
Qualifications: -/USDMF/-/-
* Please be kindly noted products are offered for R&D purpose only. Not for human or veterinary use.
| Name | Citicoline Sodium |
| Chinese name | 胞磷胆碱钠 |
| Cas Number | 33818-15-4 |
| Source | Japan |
| Qualifications | -/USDMF/-/- |
Citicoline is a nucleic acid derivatives, Geiger found that citicoline can restore brain injury in the animal experiments in 1956. Kennedy study confirmed that citicoline can make brain injury recovery in 1957. Takeda pharmaceutical company in Japan developed and produced it in 1961. It was registered in China in 1988, and is currently the best-selling drug among clinical brain diseases. It plays an important role in the synthesis of lecithin, by promoting the synthesis of lecithin and improving brain function. Experiments show that citicoline can enhance the levels of norepinephrine and dopamine in the central nervous system, thereby it can treat cerebrovascular disease, traumatic brain injury and cognitive impairment caused by various reasons, and there are no obvious side effects.
For more information please feel free to get in touch with us today!
Email: tonghuiyy218@upharm.cn
Wechat/Whatsapp: +86-189-2212-0635
Hot Tags: citicoline sodium api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Salmeterol Xinafoate API, Linagliptin API, Teriflunomide API, Pabxilib API, Deoxycholic Acid API, Active Pharmaceutical Ingredient
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
